1. Home
  2. ORI vs RGEN Comparison

ORI vs RGEN Comparison

Compare ORI & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORI
  • RGEN
  • Stock Information
  • Founded
  • ORI 1923
  • RGEN 1981
  • Country
  • ORI United States
  • RGEN United States
  • Employees
  • ORI N/A
  • RGEN N/A
  • Industry
  • ORI Property-Casualty Insurers
  • RGEN Medical/Dental Instruments
  • Sector
  • ORI Finance
  • RGEN Health Care
  • Exchange
  • ORI Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • ORI 9.9B
  • RGEN 6.5B
  • IPO Year
  • ORI N/A
  • RGEN N/A
  • Fundamental
  • Price
  • ORI $39.77
  • RGEN $146.99
  • Analyst Decision
  • ORI Strong Buy
  • RGEN Buy
  • Analyst Count
  • ORI 2
  • RGEN 11
  • Target Price
  • ORI $46.50
  • RGEN $170.90
  • AVG Volume (30 Days)
  • ORI 1.5M
  • RGEN 1.1M
  • Earning Date
  • ORI 10-23-2025
  • RGEN 10-28-2025
  • Dividend Yield
  • ORI 2.94%
  • RGEN N/A
  • EPS Growth
  • ORI N/A
  • RGEN N/A
  • EPS
  • ORI 3.32
  • RGEN 0.03
  • Revenue
  • ORI $8,748,900,000.00
  • RGEN $707,890,000.00
  • Revenue This Year
  • ORI $8.95
  • RGEN $16.79
  • Revenue Next Year
  • ORI $5.88
  • RGEN $13.58
  • P/E Ratio
  • ORI $11.90
  • RGEN $5,901.52
  • Revenue Growth
  • ORI 7.08
  • RGEN 11.74
  • 52 Week Low
  • ORI $33.00
  • RGEN $102.97
  • 52 Week High
  • ORI $44.00
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • ORI 42.01
  • RGEN 49.35
  • Support Level
  • ORI $38.78
  • RGEN $144.18
  • Resistance Level
  • ORI $39.67
  • RGEN $153.42
  • Average True Range (ATR)
  • ORI 1.01
  • RGEN 6.72
  • MACD
  • ORI -0.30
  • RGEN -2.20
  • Stochastic Oscillator
  • ORI 29.56
  • RGEN 10.94

About ORI Old Republic International Corporation

Old Republic International Corp offers a diverse range of specialized insurance products to individuals and institutions. The company operates in two segments: Specialty Insurance and Title Insurance. The Insurances provided by the company includes Automobile Extended Warranty Insurance, Aviation, Commercial Automobile Insurance, Inland Marine, Travel Accident, Workers' Compensation, Financial Indemnity, and others.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: